Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment
Tarih
2019Yazar
Tanaka, Nobuhiro
Alegria-Barrero, Eduardo
Meuwissen, Martijin
Piek, Jan J.
van Royen, Niels
Di Mario, Carlo
Gerber, Robert T.
Malik, Iqbal S.
Sharp, Andrew S. P.
Talwar, Suneel
Tang, Kare
Samady, Habib
Altman, John
Seto, Arnold H.
Singh, Jasvindar
Jeremias, Allen
Matsuo, Hitoshi
Kharbanda, Rajesh K.
Patel, Manesh R.
Serruys, Patrick
Escaned, Javier
Laine, Mika
Van Belle, Eric
Krackhardt, Florian
Bojara, Waldemar
Going, Olaf
Haerle, Tobias
Indolfi, Ciro
Davies, Justin E.
Sezer, Murat
Sen, Sayan
Ahmad, Yousif
Dehbi, Hakim-Moulay
Howard, James P.
Iglesias, Juan F.
Al-Lamee, Rasha
Petraco, Ricardo
Nijjer, Sukhjinder
Bhindi, Ravinay
Lehman, Sam
Walters, Darren
Sapontis, James
Janssens, Luc
Vrints, Christiaan J.
Khashaba, Ahmed
Niccoli, Giampaolo
Ribichini, Flavio
Yokoi, Hiroyoshi
Takashima, Hiroaki
Kikuta, Yuetsu
Erglis, Andrejs
Vinhas, Hugo
Silva, Pedro Canas
Baptista, Sergio B.
Alghamdi, Ali
Hellig, Farrel
Koo, Bon-Kwon
Nam, Chang-Wook
Shin, Eun-Seok
Doh, Joon-Hyung
Brugaletta, Salvatore
Üst veri
Tüm öğe kaydını gösterÖzet
BACKGROUND Physicians are not always comfortable deferring treatment of a stenosis in the left anterior descending (LAD) artery because of the perception that there is a high risk of major adverse cardiac events (MACE). The authors describe, using the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) trial, MACE rates when LAD lesions are deferred, guided by physiological assessment using fractional flow reserve (FFR) or the instantaneous wave-free ratio (iFR).
Koleksiyonlar
- Makale [92796]